ILMN
Illumina, Inc.
NASDAQ · USHealthcareMedical - Diagnostics & Research
$184.68-1.06%
Price as of Jul 20, 2026
ILMN capital
Illumina, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.95x
- Net debt / equity
- 0.54x
- Debt / assets
- 0.39x
- Debt / EBITDA
- 1.81x
- Net debt / EBITDA
- 1.03x
Liquidity & coverage
- Current ratio
- 1.75x
- Quick ratio
- 1.36x
- Cash ratio
- 0.74x
- Interest coverage
- 12.39x
- EBITDA / interest
- 18.53x
- Working capital
- $1.2B
Cash & dividend
- FCF / debt
- 0.39x
- Cash flow / debt
- 0.44x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.